Stock Message Board http://investorshangout.com/search?q=LGNDZ&am...mp;yt1=Go!
Last Updated: 07/20/2014 03:46:24
Current Price and Quotes
Last Price 0.012
Previous Close 0.012 Open N/A
Daily Range N/A - N/A 52wk Range 0.006 - 0.02
Volume 0 Dividend N/A
Average Vol (3m) 28,047 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 48,973 31,388 30,037 23,538
Cost of Revenue 5,732 3,601 4,909 -
Gross Profit 43,241 27,787 25,128 23,538
Operating Expenses
Research and Development 9,274 10,790 10,291 22,067
Sales, General and Admin. 17,984 15,782 12,881 11,127
Non-Recurring Items 1,040 1,022 2,834 19,648
Other - - - -
Operating Income 14,943 193 (878) (29,304)
Income From Continuing Operations
Add'l Income/Expense Items (3,660) (1,134) (383) 13,519
Earnings Before Interest and Tax 11,283 (941) (1,261) (15,403)
Interest Expense 2,077 2,924 2,297 -
Earnings Before Tax 9,206 (3,865) (3,558) (15,403)
Income Tax 374 (1,191) (13,270) (2,617)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 8,832 (2,674) 9,712 (12,786)
Non Recurring Events
Discontinued Operations 2,588 2,147 3 2,413
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 11,420 (527) 9,715 (10,373)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 11,420 (527) 9,715 (10,373)
Recent News
Jul 17, 2014 Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona Fund
Jul 17, 2014 Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program
Jul 14, 2014 Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum
Jul 8, 2014 Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne
Jul 7, 2014 Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report
Jun 30, 2014 Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta
Jun 25, 2014 Ligand Partner GSK Announces the Start of a Phase 3 Study with Eltrombopag in Patients with Myelodysplastic Syndromes
Jun 24, 2014 Lemelson Capital Reaffirms Research Report and Price Target for Ligand Pharmaceuticals (NASDAQ: LGND)
Jun 24, 2014 TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4
Jun 24, 2014 Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program
1
2
3
next >
LGNDZ Ligand Pharmaceuticals Incorporated Research DD Guide
Stock Message Board http://investorshangout.com/search?q=LGNDZ&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/LGNDZ/quote
Stock Chart http://www.otcmarkets.com/stock/LGNDZ/chart
Company Info http://www.otcmarkets.com/stock/LGNDZ/company-info
Recent News http://www.otcmarkets.com/stock/LGNDZ/news
Financials http://www.otcmarkets.com/stock/LGNDZ/financials
Filings and Disclosure http://www.otcmarkets.com/stock/LGNDZ/filings
Short Sales http://www.otcmarkets.com/stock/LGNDZ/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/LGNDZ/insider-transactions
Research Reports http://www.otcmarkets.com/stock/LGNDZ/research
Summary http://finance.yahoo.com/q?s=LGNDZ
Historical Prices http://finance.yahoo.com/q/hp?s=LGNDZ+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=LGNDZ
Basic Chart http://finance.yahoo.com/q/bc?s=LGNDZ+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LGNDZ+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=LGNDZ+Headlines
Press Releases http://finance.yahoo.com/q/p?s=LGNDZ+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=LGNDZ+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=LGNDZ+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=LGNDZ+Industry
Major Holders http://finance.yahoo.com/q/mh?s=LGNDZ+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=LGNDZ+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=LGNDZ+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=LGNDZ
Balance Sheet http://finance.yahoo.com/q/bs?s=LGNDZ
Cash Flow http://finance.yahoo.com/q/cf?s=LGNDZ+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/LGNDZ
Market Watch http://www.marketwatch.com/investing/stock/LGNDZ
Bloomberg http://www.bloomberg.com/quote/LGNDZ:US
Morningstar http://quotes.morningstar.com/stock/s?t=LGNDZ
Bussinessweek http://investing.businessweek.com/research/st...cker=LGNDZ
Barchart http://www.barchart.com/quotes/stocks/LGNDZ
OTC Short Report http://otcshortreport.com/index.php?index=LGNDZ
Investopedia http://www.investopedia.com/markets/stocks/LGNDZ/?wa=0